Search

Your search keyword '"C Gammarota"' showing total 8 results
Start Over Author "C Gammarota"
8 results on '"C Gammarota"'

1. PO480 'School For Life' (Life Style For Life Project): Culture of Prevention of Cardiovascular Diseases, Early Resuscitation and Defibrillation In Schools

Author

A. Incerto, C. Gammarota, M. Grio, Daniela Aschieri, and M. Segre

Subjects
Community and Home Care, Resuscitation, Epidemiology, Life style, business.industry, Defibrillation, medicine.medical_treatment, Medicine, Medical emergency, Cardiology and Cardiovascular Medicine, business, medicine.disease
Published
2018
Full Text
View/download PDF

2. [Infectious complications of LeVeen peritoneovenous shunt. Description of a case]

Author

M F, Franciosini, C, Gammarota, G, Polchi, G, Giordano, and E, Romoli

Subjects
Peritoneovenous Shunt, Escherichia coli, Humans, Female, Meningitis, Middle Aged, Escherichia coli Infections
Abstract

A lethal case of E. coli induced meningitis and sepsis in patient with Le Veen peritoneo-venous shunt (PVS) for refractory ascites during alcohol induced cirrhosis of the liver is reported in confirmation of the high number of infectious complications that affects the cirrhotic, especially if he has been subjected to PVS. This report owes its interest to the unusual site of the infection which is however fairly frequent in these particular patients.

Published
1990

5. Study design of the international stroke trial (IST), baseline data, and outcome in 984 randomised patients in the pilot study

Author

B Smith, H Parry, S Anderson, E Vignai, R Agosti, H Taylor, Martin Dennis, M Rinaldi, I McCrindle, C BurnsCox, Rory Collins, Ralph L. Sacco, M G Ceravolo, G Waberzinek, M DeJiuli, S Pelonara, Enrico Righetti, C Gandolfo, G Conti, M Bondi, L Munari, B Boniccioli, D. E. Kargman, G Ferraro, A Boccali, L Melini, M Arreghi, Stefano Ricci, R Migliacci, M DelSette, G Bottini, R Meara, R Tallis, S Richards, C Gammarota, N Guerrini, A Brownlie, L Robertson, M Harrison, C Majvald, Kennedy R. Lees, R Ibba, W Garuti, R Cavestri, I Scougal, M Proctor, R Croce, M Bracaccia, N Miele, L MacLean, R Lindley, A Brucato, Joanna M. Wardlaw, A Pirisi, S Biagini, M Guerrieri, M Guidotti, J Bamford, J vanGijn, M Pacini, T Comparato, C Warlow, L Antoniutti, M Cruciani, P Anzola, Richard Peto, A Mauro, M Aimi, G Micieli, A Perretti, M Cunniffe, C Finocchi, C Holland, F Sani, Peter Sandercock, E Longhini, M Crowe, Graham Venables, C Calandri, D Gori, B Biscottini, Z Ambler, Sandercock Pag., L Wilhelmsen, R Sterzi, R Luccioli, M Mathieson, J Slattery, M Franciosini, K Kafetz, Graeme J. Hankey, C McDonald, P Floridi, R Fogelholm, D Farquhar, Manuel Correia, T Jolma, C Corbacelli, H Fraser, M Livingstone, E Colquohoun, M Mollaioli, S Honeyman, F Waddell, F C Grandi, M Conti, F Pezzella, R Valli, P Dove, J MacKenzie, G Alunni, C P Warlow, Richard I. Lindley, G Celani, P Indekeu, M Mangoni, E Ciorba, L Provinciali, D Charlton, V Scoltock, G Benemio, M Gregori, R Sellar, G Moody, G Malferrari, and S Grasselli

Subjects
Adult, medicine.medical_specialty, Time Factors, Pilot Projects, Outcome (game theory), Brain Ischemia, Recurrence, medicine, Humans, Multicenter Studies as Topic, Cluster randomised controlled trial, Stroke, Aged, Randomized Controlled Trials as Topic, Aged, 80 and over, Aspirin, business.industry, Heparin, Anticoagulants, Baseline data, Middle Aged, medicine.disease, Psychiatry and Mental health, Treatment Outcome, Research Design, Acute Disease, Physical therapy, Feasibility Studies, Surgery, Neurology (clinical), business, medicine.drug, Research Article
Abstract

BACKGROUND AND PURPOSE: To test the design and feasibility of a very large randomised controlled trial assessing the efficacy and safety of antithrombotic therapy started within 48 hours of symptom onset in patients with suspected acute ischaemic stroke. DESIGN: Randomised controlled multicentre open study, with a 3 x 2 factorial design, allocating patients to: medium dose subcutaneous heparin (12,500 units twice per day), versus low dose subcutaneous heparin (5000 units twice per day) versus no heparin; and aspirin (300 mg daily) versus no aspirin. Treatment was given for two weeks or until discharge from hospital if sooner. RESULTS: 984 patients were randomised. CT was performed in 924 (94%) (before randomisation in 622/984 (63%). Within 14 days: 97 patients had died (10%), 30 (3.0%) had a fatal or non-fatal recurrent ischaemic stroke, nine (0.9%) had fatal or non-fatal recurrent stroke due to intracranial haemorrhage, and eight (0.8%) had a fatal or non-fatal pulmonary embolus. At six months, vital status was known for 975 patients (99%), of whom 210 (22%) were dead, 373 (38%) were alive but dependent, and 225 (23%) were independent but not fully recovered. CONCLUSIONS: The trial procedures proved practicable and a wide variety of patients were recruited. Sample size calculation based on the event rates confirmed that reliable evidence on the balance of risk and benefit of early antithrombotic therapy might require a study with more than 20,000 patients. Recruitment rates in the pilot study indicated that if about 200 hospitals participated, recruitment could be completed by 1997.

6. [Infectious complications of LeVeen peritoneovenous shunt. Description of a case].

Author

Franciosini MF, Gammarota C, Polchi G, Giordano G, and Romoli E

Subjects
Escherichia coli isolation & purification, Escherichia coli Infections mortality, Female, Humans, Meningitis mortality, Middle Aged, Escherichia coli Infections etiology, Meningitis etiology, Peritoneovenous Shunt adverse effects
Abstract

A lethal case of E. coli induced meningitis and sepsis in patient with Le Veen peritoneo-venous shunt (PVS) for refractory ascites during alcohol induced cirrhosis of the liver is reported in confirmation of the high number of infectious complications that affects the cirrhotic, especially if he has been subjected to PVS. This report owes its interest to the unusual site of the infection which is however fairly frequent in these particular patients.

Published
1990

Catalog

Books, media, physical & digital resources
See catalog results